TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today ...
ANDOVER, Mass., Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. (TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and ...
ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Wednesday reported third-quarter net income of $24.3 million. The Andover, Massachusetts-based company said it had profit ...
ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Tuesday reported fourth-quarter earnings of $105.4 million. On a per-share basis, the Andover, Massachusetts-based company ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A biotechnology company that ...
ANDOVER, Mass., Nov. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
ANDOVER, Mass., May 8, 2025 /PRNewswire/ -- TransMedics Group, Inc. (TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results